PF-Atlas › Clinical Trials › NCT00966602

Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects

VX-809 · Phase 1

Registry ID

NCT00966602

Phase

Phase 1

Status

Completed

Drug / intervention

VX-809

Sponsor

Vertex Pharmaceuticals Incorporated

Start

2009-09

About this trial

VX-809 is evaluated in NCT00966602, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Vertex Pharmaceuticals Incorporated. Current status: Completed.

View NCT00966602 on ClinicalTrials.gov →

Explore related

All VX-809 trials All IPF trials

Related trials

VX-809 — NCT02514473

Medical disclaimer. This page summarizes public trial data for NCT00966602 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.